Colorectal cancer (CRC) is the second popular cancer in females and third in males, with an increased number of cases. Pathology diagnoses complemented with predictive and prognostic biomarker information is the first step for personalized treatment. Histopathological image (HI) analysis is the benchmark for pathologists to rank colorectal cancer of various kinds. However, pathologists' diagnoses are highly subjective and susceptible to inaccurate diagnoses. The improved diagnosis load in the pathology laboratory, incorporated with the reported intra- and inter-variability in the biomarker assessment, has prompted the quest for consistent machine-based techniques to be integrated into routine practice. In the healthcare field, artificial intelligence (AI) has achieved extraordinary achievements in healthcare applications. Lately, computer-aided diagnosis (CAD) based on HI has progressed rapidly with the increase of machine learning (ML) and deep learning (DL) based models. This study introduces a novel Colorectal Cancer Diagnosis using the Optimal Deep Feature Fusion Approach on Biomedical Images (CCD-ODFFBI) method. The primary objective of the CCD-ODFFBI technique is to examine the biomedical images to identify colorectal cancer (CRC). In the CCD-ODFFBI technique, the median filtering (MF) approach is initially utilized for noise elimination. The CCD-ODFFBI technique utilizes a fusion of three DL models, MobileNet, SqueezeNet, and SE-ResNet, for feature extraction. Moreover, the DL models' hyperparameter selection is performed using the Osprey optimization algorithm (OOA). Finally, the deep belief network (DBN) model is employed to classify CRC. A series of simulations is accomplished to highlight the significant results of the CCD-ODFFBI method under the Warwick-QU dataset. The comparison of the CCD-ODFFBI method showed a superior accuracy value of 99.39% over existing techniques.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794880 | PMC |
http://dx.doi.org/10.1038/s41598-024-83466-5 | DOI Listing |
Keio J Med
March 2025
Center for Hereditary Breast and Ovarian Cancer Syndrome, Keio University Hospital, Tokyo, Japan.
Hereditary breast and ovarian cancer syndrome (HBOC) is traditionally associated with mutations in the BRCA1 and BRCA2 genes, predominantly impacting breast, ovarian, pancreatic, and prostate cancers. However, recent research suggests that these mutations may also predispose carriers to a broader spectrum of malignancies, including biliary tract, cervical, colorectal, endometrial, esophageal, and gastric cancers. This review presents findings from extensive datasets, including a significant study from a nationwide Japanese biobank that examined cancer risks in 63,828 patients and 37,086 controls.
View Article and Find Full Text PDFFitoterapia
March 2025
Innovative Practice Platform for Research-oriented Teaching of Natural Product Resources Development and Application, School of Food Science and Chemical Engineering, Zhengzhou University of Technology, Zhengzhou, Henan 450044, China.
A series of novel amide-fused isosteviol derivatives were designed and synthesized. Their cytotoxicities in vitro against HCT-116 cells were screened. The preliminary bioassays indicated that most of the title compounds exhibited noteworthy cytotoxicity.
View Article and Find Full Text PDFGan To Kagaku Ryoho
February 2025
Dept. of Gastroenterological Surgery, Sakai City Medical Center.
A 66-year-old woman presented with discharge of necrotic tissue and bleeding from the vagina during uterine cancer screening. She was diagnosed with lower rectal cancer cT4b(vagina)N3M0, cStage Ⅲc. As the tumor protruded into the lumen from the posterior vaginal wall, preservation of the anterior vaginal wall was challenging.
View Article and Find Full Text PDFGan To Kagaku Ryoho
February 2025
Dept. of Surgery, Tokyo Women's Medical University Adachi Medical Center.
We investigated the short-term outcomes of robot-assisted surgery for rectal cancer in our department. Among 98 cases of colorectal cancer who underwent robot-assisted surgery between October 2019 and December 2023, 91 cases of rectal cancer surgery using the da Vinci X surgical system® were included, and clinicopathological and surgical outcomes were examined. The patients included 58 males and 33 females, with a median age of 71 years.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!